Hepatitis B virus wild-type and rtN236T populations show similar early HBV DNA decline in adefovir refractory patients on a tenofovir-based regimen. (Q45353143)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 July 2012

Language	Label	Description	Also known as
English	Hepatitis B virus wild-type and rtN236T populations show similar early HBV DNA decline in adefovir refractory patients on a tenofovir-based regimen.	scientific article published on 9 July 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Hepatitis B virus wild-type and rtN236T populations show similar early HBV DNA decline in adefovir refractory patients on a tenofovir-based regimen (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

E S Svarovskaia

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

M Curtis

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Y Zhu

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

K Borroto-Esoda

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

M D Miller

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

F Lavocat

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

K M Kitrinos

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

9 July 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

131-140

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01638.X

21 January 2018

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01638.X

21 January 2018

Four years of lamivudine treatment in Chinese patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01638.X

21 January 2018

Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01638.X

21 January 2018

Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01638.X

21 January 2018

Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01638.X

21 January 2018

No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01638.X

21 January 2018

Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01638.X

21 January 2018

Quantifying mixed populations of drug-resistant human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01638.X

21 January 2018

MultiCode-RTx real-time PCR system for detection of subpopulations of K65R human immunodeficiency virus type 1 reverse transcriptase mutant viruses in clinical samples

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01638.X

21 January 2018

In vitro characterization of viral fitness of therapy-resistant hepatitis B variants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01638.X

21 January 2018

Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01638.X

21 January 2018

Complex dynamics of hepatitis B virus resistance to adefovir

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01638.X

21 January 2018

Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01638.X

21 January 2018

Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2012.01638.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2012.01638.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23301548%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45353143&oldid=1420814049"